| AI | Artificial intelligence |
| ACS | Acute coronary syndrome |
| AHA | American Heart Association |
| AMI | Acute myocardial infarction |
| AMR | Antimicrobial resistance |
| CAD | Coronary artery disease |
| CAMA | Coronary artery mycotic aneurysm |
| CT | Computed tomography |
| DES | Drug-eluting stents |
| EE | Embolic events |
| ESC | European Society of Cardiology |
| IE | Infective endocarditis |
| GD | Graves’ disease |
| HF | Heart failure |
| IBD | Inflammatory bowel disease |
| JACC | Journal of the American College of Cardiology |
| IVDA | Intravenous drug abusers |
| LAD | Anterior descending artery |
| LCX | Left coronary circumflex artery |
| LMCA | Left main coronary artery |
| LSE | Libman–Sacks endocarditis |
| MIC | Minimum inhibitory concentration |
| MRI | Cardiac magnetic resonance |
| MRSA | Methicillin-resistant Staphylococcus aureus |
| MS | Multiple sclerosis |
| MSSA | Methicillin-susceptible Staphylococcus aureus |
| NSTEMI | NON-ST elevation myocardial infarction |
| NVE | Native valve endocarditis |
| PREMs | Patient-reported Experience Measures |
| PROMs | Patient-reported Outcome Measures |
| PVE | Prosthetic valve endocarditis |
| RA | Rheumatoid arthritis |
| RCA | Right coronary artery |
| SLE | Systemic lupus erythematosus |
| STEMI | ST elevation myocardial infarction |
| TDM | Therapeutic drug monitoring |
| TOE | Transesophageal cardiac ultrasound |
| TTE | Transthoracic cardiac ultrasound |
| T1D | Type 1 diabetes |
| T2D | Type 2 diabetes |
| UI | Uncontrolled infection |
| WHO | World Health Organization |